Key facts
- Notable investors include Transpose Platform Management, Entrepreneurs First, No Label Ventures.
- Status: Privately Held (backing).
- ·The complete investor list — 3 names
- ·Watchlist + deal alerts for Uncovr
- ·The full record, as it builds
Funding rounds
No funding rounds for Uncovr are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Uncovr
Developer of artificial intelligence-powered surgical documentation software designed to automate operative note generation and billing capture from surgical video. The company's platform analyzes surgical video recordings using computer vision and artificial intelligence technology to automatically detect billable events, generate compliant and structured operative notes that reduce documentation time, and integrate with electronic health record systems, enabling clients to reduce administrative workload, improve billing accuracy, capture revenue from documented procedures, and enhance patient safety through surgical documentation.
- Sector
- Healthcare
- HQ
- San Francisco, CA, United States
- Employees
- 2
- Website
- uncovrsurgical.com/
- Ownership
- Privately Held (backing)
Uncovr doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Uncovr shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Uncovr in its N-PORT filings yet. We sweep new filings monthly.